Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $24.3500 (-2.56%) ($24.3000 - $25.4200) on Mon. Sep. 23, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.8% (three month average) | RSI | 56 | Latest Price | $24.3500(-2.56%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.1% a day on average for past five trading days. | Weekly Trend | EDIT advances 1.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(63%) ARKG(59%) IWO(58%) XBI(58%) ARKK(55%) | Factors Impacting EDIT price | EDIT will decline at least -1.4% in a week (0% probabilities). VIXM(-32%) VXX(-17%) UUP(-6%) TLT(-3%) SHY(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.4% (StdDev 2.8%) | Hourly BBV | 0 () | Intraday Trend | -2.1% | | | |
|
Resistance Level | $24.89 | 5 Day Moving Average | $25.11(-3.03%) | 10 Day Moving Average | $25.47(-4.4%) | 20 Day Moving Average | $24.89(-2.17%) | To recent high | -9.2% | To recent low | 11.7% | Market Cap | $1.512b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |